Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS unilife corporation

0.00%

0.5¢

This share has been going the same way for so long, had so many...

First 2 Last

Share
Profile

Follow
Radish

4,142 Posts.

12

19/02/17

12:39

Post #: 22730138
Share

Originally posted by Unifollower ↑

This SEC filing in Dec 16- talks about debt being repaid to Amgen from product discounts and or lump sum repayment-
Interest under the December 2016 Convertible Note accrues at a rate of 6% per year and will be paid quarterly in arrears through the addition of the amount of such interest to the then outstanding principal amount. All or part of the principal and accrued interest will be repaid through (i) discounted pricing on purchases by the Counterparty of the Company’s products, (ii) credits taken by the Counterparty against development and customization fees for devices, and (iii) credits against per-unit royalties otherwise payable to the Company for the manufacture and sale of the Company’s products. To the extent that more than one Note is outstanding, repayment shall be applied to the Notes in the order of their issuance. In addition, the Company has the right to prepay in cash all or part of the principal and accrued interest at any time upon 15 business days’ prior notice, subject to the Counterparty’s conversion right with respect to the contemplated prepayment amount. The Company is required to pay in cash any amounts of principal and accrued interest outstanding at February 22, 2023 (the “Maturity Date”).

In addition Orbimed has stepped in to prevent vultures buying shares at rediculous low prices causing massive dilution.

Unless everyone involved are 'yanking each others chain' then there is a lot being negotiated with a floor price established.

Imagine what will happen to the SP if enough cash flows in to repay loans and prevent premises being sold.
I believe this is not a wild possibility for the following reasons-
1-The above SEC filing
2- Orbimeds placing a floor price on taking a strategic stake .
3-Flextronics very public endorsement of Unilife and their strategic alliance involving commercial development and production.
4- Sanofi must take a strategic stake in this new technology. They have no other commercial alternative.
5- I believe Flextronics already produces wearable pumps for the diabetic market and they do not refer to them as worlds best technology.
6- The existing wearable pump being used for transferring vials to the pump device- involves multiple steps and a single use transfer attachment, which apart from being inconvenient and cumbersome, requires dexterity and skill.

I have a hunch that the factory will not need to be sold

I also reserve the right to be wrong and to make or lose money on my UNS investment.
There is some speculation but not all in this post.

Expand

This share has been going the same way for so long, had so many promises that don't come true. This is my first comment for years on this share and I think 6 suspensions related to bagging it but to those who listened great and those who didn't, best of luck as you will need it. Lol.

UNS Price at posting: 4.4¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

WIN

'Incorrect datasets': Old irony sets WIN Metals up for golden opportunity at Emjay

ASX Market Close: Tariff fatigue truly evident; RBA eftpos proposal sinks Tyro

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

AII

Inside the depths of Panasqueira: A legacy carved in rock

Tuesday's HotCopper trends: Sayona intercepts, Bowen Coking crisis | July 15

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

This share has been going the same way for so long, had so many...

Top Stories

'Incorrect datasets': Old irony sets WIN Metals up for golden opportunity at Emjay

ASX Market Close: Tariff fatigue truly evident; RBA eftpos proposal sinks Tyro

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Inside the depths of Panasqueira: A legacy carved in rock

Tuesday's HotCopper trends: Sayona intercepts, Bowen Coking crisis | July 15

Featured News